Pharmaceutical Technology29 天
Golidocitinib by Dizal Pharmaceutical for Unspecified Immunological Disorders: Likelihood ...
Golidocitinib (DZD-4205) is under development for the treatment of non-small cell lung cancer and T cell lymphomas including peripheral T cell lymphoma, vascular immunoblast type (AITL), Anaplastic ...
Pharmaceutical Technology1 个月
Golidocitinib by Dizal Pharmaceutical for Peripheral T-Cell Lymphomas (PTCL): Likelihood of ...
Golidocitinib (DZD-4205) is under development for the treatment of non-small cell lung cancer and T cell lymphomas including peripheral T cell lymphoma, vascular immunoblast type (AITL), Anaplastic ...